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MaOBJECTIVES This study aimed to determine whether remote ischemic conditioning (RIC) initiated prior to primary
percutaneous coronary intervention (PPCI) could reduce myocardial infarct (MI) size in patients presenting with
ST-segment elevation myocardial infarction.
BACKGROUND RIC, using transient limb ischemia and reperfusion, can protect the heart against acute ischemia-
reperfusion injury. Whether RIC can reduce MI size, assessed by cardiac magnetic resonance (CMR), is unknown.
METHODS We randomly assigned 197 ST-segment elevation myocardial infarction patients with TIMI (Thrombolysis
In Myocardial Infarction) ﬂow grade 0 to receive RIC (four 5-min cycles of upper arm cuff inﬂation/deﬂation) or control
(uninﬂated cuff placed on upper arm for 40 min) protocols prior to PPCI. The primary study endpoint was MI size,
measured by CMR in 83 subjects on days 3 to 6 after admission.
RESULTS RIC reduced MI size by 27%, when compared with the MI size of control subjects (18.0  10% [n ¼ 40] vs.
24.5  12.0% [n ¼ 43]; p ¼ 0.009). At 24 h, high-sensitivity troponin T was lower with RIC (2,296  263 ng/l [n ¼ 89]
vs. 2,736  325 ng/l [n ¼ 84]; p ¼ 0.037). RIC also reduced the extent of myocardial edema measured by T2-mapping
CMR (28.5  9.0% vs. 35.1  10.0%; p ¼ 0.003) and lowered mean T2 values (68.7  5.8 ms vs. 73.1  6.1 ms;
p ¼ 0.001), precluding the use of CMR edema imaging to correctly estimate the area at risk. Using CMR-independent
coronary angiography jeopardy scores to estimate the area at risk, RIC, when compared with the control protocol,
was found to signiﬁcantly improve the myocardial salvage index (0.42  0.29 vs. 0.28  0.29; p ¼ 0.03).
CONCLUSIONS This randomized study demonstrated that in ST-segment elevation myocardial infarction patients
treated by PPCI, RIC, initiated prior to PPCI, reduced MI size, increased myocardial salvage, and reduced myocardial
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AB BR E V I A T I O N S
AND ACRONYM S
AAR = area at risk
AUC = area under the curve
CMR = cardiac magnetic
resonance
hsTnT = high-sensitivity
troponin T
LGE = late gadolinium
enhancement
LV = left ventricular
MI = myocardial infarct
MSI = myocardial salvage index
PCI = percutaneous coronary
intervention
PPCI = primary percutaneous
coronary intervention
RIC = remote ischemic
conditioning
STEMI = ST-segment elevation
myocardial infarction
STIR = short tau inversion
recovery
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179D espite optimalmyocardial reperfusion usingprimary percutaneous coronary interven-tion (PPCI), the morbidity and mortality of
ST-segment elevation myocardial infarction (STEMI)
patients remains substantial. One neglected therapeu-
tic target, in these patients, is myocardial reperfusion
injury, which describes myocardial injury and cell
death that results, paradoxically, from reperfusing
an acutely ischemic myocardium, and which contrib-
utes up to 50% of the ﬁnal myocardial infarct (MI)
size (1). Novel therapeutic interventions are required
to protect the heart against myocardial reperfusion
injury in order to reduce MI size, preserve left ven-
tricular (LV) systolic function, and improve clinical
outcomes in this patient group (2).
Remote ischemic conditioning (RIC) has emerged
as a novel therapeutic intervention for protecting the
heart against acute ischemia-reperfusion injury. RIC
describes the endogenous cardioprotective effect
elicited by applying $1 brief nonlethal cycle of
ischemia and reperfusion to an organ or tissue
remote from the heart (3,4). In the clinical setting,
this can be implemented by inﬂating a blood pressure
cuff placed on the upper arm or thigh to induce the
RIC stimulus in the arm or leg (5). This noninvasive,
low-cost, therapeutic intervention has been reported
to be beneﬁcial in patients undergoing coronary ar-
tery bypass graft surgery (6,7), and elective percuta-
neous coronary intervention (PCI) (8). More recently,
RIC has been investigated in STEMI patients treated
by PPCI (9,10).
Cardiac magnetic resonance (CMR) has emerged as
the imaging modality of choice to assess the car-
dioprotective efﬁcacy of novel therapeutic inter-
ventions in PPCI-treated STEMI patients. CMR
accurately and reproducibly measures MI size (11),
but more importantly, can also measure the
myocardial salvage index (MSI) (12). MSI is a sensitive
measure of cardioprotective efﬁcacy, representing
the proportion of the myocardium at risk of infarction
“rescued” by a therapeutic intervention—this re-
quires that the myocardium or area at risk (AAR) be
quantiﬁed. The current CMR method for in vivo AAR
estimation is to use T2-weighted CMR imaging 2 to 7
days following PPCI to delineate the extent of
myocardial edema (13–15). Recent studies of novel
cardioprotective interventions have used MSI to
demonstrate efﬁcacy without reduction in absolute
infarct size (16,17), but it has also been reported that
the therapeutic intervention may itself reduce the
extent of infarct-related myocardial edema (18),
thereby precluding its use for calculating MSI.
Whether RIC can reduce MI size and, potentially,
myocardial edema is unknown. In the current study,we use CMR to assess the cardioprotective
efﬁcacy of RIC in STEMI patients treated by
PPCI.METHODS
STUDY POPULATION. This study was
approved by the UK National Research Ethics
Service. Written informed consent was ob-
tained from all participants. Patients were
recruited in a consecutive manner from the
Essex Cardiothoracic Centre between July 1,
2011 and April 30, 2013. Patient inclusion
criteria were the following: age 18 to 80
years; presentation within 12 h of onset of
chest pain, and ECG showing ST-segment
elevation of $0.1 mV in 2 contiguous leads
($0.2 mV in leads V1 to V3); pre-PCI TIMI
(Thrombolysis In Myocardial Infarction) ﬂow
grade <1. Patient exclusion criteria were the
following: cardiac arrest (pre- or post-PPCI
procedure); cardiogenic shock; previous MI
or coronary artery bypass graft surgery; sig-
niﬁcant coronary collateralization to the AAR (Rent-
rop grade $1); and any contraindication to CMR
imaging.
EXPERIMENTAL PROTOCOL. In order to protect the
heart against myocardial reperfusion injury, the
therapeutic intervention has to be initiated prior to
myocardial reperfusion. As such, patients were
randomly assigned to either RIC or control protocols
on arrival in hospital, and the allocated treatment
was initiated prior to PPCI. A computer-generated
randomization sequence was used. Sequentially
numbered, sealed envelopes were opened after con-
sent had been obtained, and these contained the
study group assignment. Randomization, treatment
allocation, and delivery of RIC were all performed by
an unblinded investigator who was not involved with
data collection or analysis. The PPCI operator, cath-
eter laboratory and coronary care unit staff, the
investigator collecting and analyzing the data, and
the investigators analyzing the coronary angiograms
and CMR scans were all blinded to the treatment
allocation.
In patients randomized to the RIC treatment arm, a
standard blood pressure cuff was placed on the upper
arm and inﬂated to 200 mm Hg and left inﬂated at
this pressure for 5 min. The cuff was then completely
deﬂated and left for 5 min. This cycle was repeated 4
times, so that the total duration of the intervention
was 40 min. If the patient’s systolic blood pressure
was >185 mm Hg, the cuffs were inﬂated to 15 mm Hg
FIGURE 1 Study Pr
The ﬂow chart shows
the study. AUC ¼ ar
sensitivity troponin T
Thrombolysis In Myo
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180above that level. For radially performed PPCI, the RIC
protocol was performed on the contralateral arm. In
patients randomized to the control treatment arm, a
standard blood pressure cuff was placed on the upper
arm and left uninﬂated for 40 min. The delivery of
the RIC or control protocols did not delay the onset of
PPCI (i.e., no delay in door-to-balloon time). If
required, the protocols were continued and over-
lapped with the PPCI procedure.
Patients underwent PPCI according to local prac-
tice. The randomization affected no other aspect of
treatment—speciﬁcally, the choice of adjunctive PPCI
management was left entirely at the discretion of theoﬁle
how patients were randomized to the control group and remote ischemic con
ea under the curve; CABG ¼ coronary artery bypass graft; CMR ¼ cardiac ma
; MI ¼ myocardial infarct; NSTEMI ¼ non–ST-segment elevation myocardial in
cardial Infarction.blinded PPCI operator (thrombectomy, antiplatelet
agents, and antithrombotic therapy). Blood samples
were taken for high-sensitivity troponin T (hsTnT) at
time 0 (prior to PPCI), 6, 12, and 24 h post-PPCI. A
CMR scan was performed on days 3 to 6 post-PPCI.
STUDY ENDPOINTS. The pre-deﬁned primary study
endpoint was MI size measured by CMR and
expressed as a percent of the LV mass. Secondary
study endpoints included: MI size measured by peak
levels of hsTnT and 24-h area-under-the-curve (AUC)
hsTnT; MSI (deﬁned as the AAR minus the MI size as a
proportion of the AAR); the presence of microvascularditioning (RIC) protocols and the primary and secondary endpoints of
gnetic resonance; CVA ¼ cardiovascular accident; hsTnT ¼ high-
farction; PPCI ¼ primary percutaneous coronary intervention; TIMI ¼
TABLE 1 Baseline Patient Characteristics and Treatments
Patients With CMR Per-Protocol Patients
Control Group
(n ¼ 40)
RIC Group
(n ¼ 43)
Control Group
(n ¼ 98)
RIC Group
(n ¼ 99)
Age, yrs 60  11 57  10 61  10 58  10
Male/female 30/10 37/6 76/22 81/18
BMI, kg/m2 29.2  4.6 28.8  4.4 27.9  4.4 28.7  4.7
Smoking 21 (52) 20 (47) 53 (54) 47 (47)
Hypertension 12 (30) 8 (19) 30 (31) 22 (22)
Dyslipidemia 13 (33) 10 (23) 29 (30) 27 (27)
Medically treated diabetes 5 (13) 1 (2) 9 (9) 4 (4)
Family history of CAD 6 (15) 10 (23) 15 (15) 20 (20)
Pre-infarct angina 4 (10) 5 (12) 11 (11) 11 (11)
Duration of ischemia, min 189 (131–290) 183 (129–278) 183 (131–283) 185 (131–288)
Time from RIC to
reperfusion, min
N/A 17.5 (13–23) N/A 16.0 (15–19)
Treatment at time of PPCI
Thrombectomy as ﬁrst
procedural device
32 (80) 35 (81) 74 (76) 84 (85)
Aspirin 40 (100) 43 (100) 98 (100) 99 (100)
Clopidogrel 35 (88) 34 (79) 74 (76) 69 (70)
Prasugrel 5 (12) 9 (21) 24 (24) 30 (30)
Abciximab 7 (18) 4 (9) 13 (13) 13 (13)
Bivalirudin 27 (68) 23 (53) 57 (58) 51 (51)
Values are mean  SD, n, n (%), or median (interquartile range).
BMI ¼ body mass index; CAD ¼ coronary artery disease; CMR ¼ cardiac magnetic resonance; N/A ¼ not
applicable; PPCI ¼ primary percutaneous coronary intervention; RIC ¼ remote ischemic conditioning.
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181obstruction on late gadolinium enhancement (LGE)
imaging; absolute and indexed LV volumes and
ejection fraction.
High-sens i t i v i ty tropon in T . This was measured
quantitatively by a 1-step enzyme immunoassay on
the basis of electro-chemiluminescence technology
(Elecsys 2010, Roche, Switzerland). This assay can
allow detection of concentrations <1.0 ng/l. These
assays measure the upper reference limit with a co-
efﬁcient of variation <10%. The threshold level of
$14.0 ng/l indicates signiﬁcant myocardial necrosis.
CMR imaging of myocard ia l infarct s i ze and
myocard ia l edema. All CMR imaging studies were
performed on a 1.5-T MAGNETOM Avanto scanner
(Siemens Healthcare, Erlangen, Germany) 3 to 6 days
after admission for PPCI using a standard acute
myocardial infarction protocol (19). LV volumes and
mass measurements were calculated conventionally
using dedicated software (CMR tools, Cardiovascular
Imaging Solutions, London, United Kingdom), with
papillary muscles considered as part of the LV
myocardium. MI size was assessed by LGE CMR im-
aging 10 min after the injection of gadolinium
(0.1 mmol/kg at 3 ml/s; Dotarem, Guerbet, France)
with standard segmented “fast low angle single shot”
inversion recovery gradient-echo sequence. The
extent of myocardial edema (i.e., the AAR) corre-
sponded to the area of increased T2 values on native
(pre-contrast), parametric T2-mapping CMR imaging,
when compared with the remote noninfarcted
myocardium (20,21). A full stack of matched short-
axis slices, 10 mm apart, was acquired of both LGE
and T2 maps to cover the LV from base to apex.
All CMR images were analyzed blinded to the
treatment allocation and clinical details of each pa-
tient. Analysis of MI size and extent of myocardial
edema was performed using an in-house macro
written in ImageJ (National Institutes of Health,
Bethesda, Maryland) (22). After manual tracing of the
epicardial and endocardial borders, the areas of MI
were quantiﬁed on LGE images using the semi-
automated Otsu detection method, as previously
validated by Vermes et al. (23) and further validated
by our group as it gave the lowest inter- and intra-
observer variability when compared with 9 other
techniques (S. White, unpublished data, January
2014). Subendocardial zones of “dark” hypo-
enhancement (microvascular obstruction  intra-
myocardial hemorrhage) within the area of
hyperenhancement, were included in the infarct area.
MI size equaled the total area of LGE expressed as a
percent of the total area of LV myocardium. The mass
of the MI (in grams of tissue) was calculated as:
S(total LGE area [cm2]  slice thickness [cm] myocardium-speciﬁc density [1.05 g/cm3], and then
indexed to the body surface area.
T2-mapping CMR (20,21) was used to measure the
extent of myocardial edema, as this sequence has
been reported to be less susceptible to the imaging
artefacts associated with traditional black-blood
T2-weighted CMR sequences, in particular, short tau
inversion recovery (STIR) (21). The area of myocardial
edema was quantiﬁed in the same way as for LGE,
using the same semiautomated Otsu detection
method (23) in LGE-matched slices (S. White, un-
published data, January 2014). Myocardial edema was
assessed further—extrapolation of work by Higgins
et al. (24) showing a linear relationship between T2
values and percent of tissue water, might be infer-
red—by manually drawing regions of interest of the
same size within: 1) the AAR, on T2 maps, avoiding the
presence of a central core of low T2 values correspond-
ing to microvascular obstruction  intramyocardial
hemorrhage; and 2) the remote myocardium, as previ-
ously described (18), to obtain mean T2 values. Our
methodology differed slightly from that by Thuny et al.
(18) in that the whole of the AAR, and remote myocar-
dium, was sampled (5 slice estimates per subject).
Furthermore, the derivation of a signal intensity ratio
was not required as absolute T2 values are provided
by the map.
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182CORONARY ANGIOGRAPHIC ANALYSIS. In order to
provide an additional CMR-independent measure of
the AAR, coronary angiograms were analyzed by 2
independent investigators blinded to the treatment
allocation using the BARI (Bypass Angioplasty
Revascularization Investigation) trial (25) and modi-
ﬁed APPROACH (Assessment on the Prevention of
Progression by Rosiblitazone on Atherosclerosis in
Diabetes Patients With Cardiovascular History) trial
(26) angiographic scores. The AAR values determined
by these 2 techniques were then used to estimate
the MSI: combining CMR-derived infarct size (LGE, %
LV) with the score (%LV) as previously described
(27,28) and calculated as detailed earlier.
SAMPLE SIZE ESTIMATION AND STATISTICAL
ANALYSIS. The primary endpoint of the study was
MI size as measured by LGE CMR. In order to detect a
25% reduction in MI size (10-g infarct mass) from an
infarct mass of 40  14 g (29) with 90% power, and at
the 0.05 2-sided signiﬁcance level, we would require
a sample size of 42 per group, which equates to a total
of 84 patients. Because of the need to commence the
RIC protocol before reperfusion, randomization had
to occur prior to PPCI, but also before a deﬁnitive
decision could be made as to whether the patient had
met speciﬁc inclusion criteria (e.g., TIMI ﬂow grade
0). Therefore, it was expected that a large number of
patients would be randomized and then later
excluded from the study.
Continuous data were reported as mean  SD (for
data approximately normally distributed) or medianTABLE 2 Angiographic Findings (Per-Protocol Analysis)
Patients With CMR
Control Group RIC Group
Differe
(95%
Angiographic ﬁndings 40 43
Infarct-related artery
LAD 17 (43) 17 (40)
CX 4 (10) 6 (14)
RCA 19 (47) 20 (47)
TIMI ﬂow grade after PPCI
3 39 (97.5) 34 (79) N/A
2 1 (2.5) 9 (21) N/A
AAR by angiographic score, %LV
BARI score 31.8  7 29.4  6 2.4
(-0.3 to
APPROACH score 32.8  8 30.3  7 2.5
(-0.8 to
Values are n, n (%), or mean  SD, unless otherwise stated.
AAR ¼ area at risk; APPROACH ¼ Assessment on the Prevention of Progression by
BARI ¼ Bypass Angioplasty Revascularization Investigation; CI ¼ conﬁdence interval; CX
ventricle; RCA ¼ right coronary artery; TIMI Thrombolysis In Myocardial Infarction; otheand interquartile range (for non-normally distributed
data). Categorical data were reported as frequencies
and percents. Categorical variables were com-
pared with the chi-square test or Fisher exact test in
the case of small cell sizes. Similarly, the unpaired
Student t test was used to compare continuous vari-
ables between 2 independent groups, ensuring
ﬁrst that the data was approximately normally
distributed for the unadjusted analysis. Covariate-
adjusted analyses were performed using multivari-
able logistic regression for continuous outcome
variables. The assumptions of the linear regression
models were assessed using residual analysis.
Difference in medians was compared with the
Wilcoxon-Mann-Whitney test. The standard error of
medians and conﬁdence intervals of the difference in
hsTnT medians were calculated using the bootstrap
method (30). The statistical analysis was conducted
using SPSS (version 20, SPSS Inc., IBM, Armonk, New
York) and Stata (version 12, Stata Corporation, College
Station, Texas). All tests were 2-sided. A p value
of <0.05 was considered statistically signiﬁcant.
RESULTS
A total of 363 patients with suspected STEMI were
screened for study eligibility. Of these, 323 patients
were randomized to receive either RIC or control
protocols on immediate arrival at the PPCI center
and proceeded to coronary angiography to conﬁrm
the diagnosis of STEMI and to exclude patients withPer-Protocol Analysis
CMR Not Performed
nce
CI) p Value Control Group RIC Group
Difference
(95% CI) p Value
58 56
25 (43) 26 (46)
10 (17) 5 (9)
23 (40) 25 (45)
0.03 54 (93) 50 (89) N/A 0.70
4 (7) 6 (11) N/A
5.2)
0.09 29.6  7 29.2  7 0.4
(-2.2 to 3.1)
0.76
5.9)
0.14 30.1  7 29.8  7 0.3
(-2.5 to 3.1)
0.83
Rosiblitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History;
¼ circumﬂex artery; LAD ¼ left anterior descending artery; %LV ¼ percent of left
r abbreviations as in Table 1.
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183pre-PPCI TIMI ﬂow grade >0 (Figure 1): 1) 164 of
these patients were randomized to the control
group, of whom 98 patients were eligible for per-
protocol analysis, with 84 patients being included
in the analysis for hsTnT levels, and of those 84
patients, 40 patients were analyzed for CMR out-
comes; 2) 159 of these patients were randomized to
the RIC group, of whom 99 patients were eligible
for the per-protocol analysis, with 89 patients
ﬁnally being analyzed for hsTnT levels, and of those
89 patients, 43 patients were analyzed for CMR
outcomes. There were no major differences in the
baseline patient characteristics and treatments be-
tween the 2 study arms (Tables 1 and 2). In the
majority of patients, the RIC or control protocols
overlapped with the beginning of the PPCI proce-
dure, and blinding of the PPCI operator was main-
tained as the protocol was continued underneath
the sterile drapes. There were no reported adverse
outcomes with RIC. Representative CMR imagesFIGURE 2 Representative CMR Images From 3 Patients
(A to C) Color parametric T2 maps depict the area of myocardial edema
infarct size in the short-axis view, and then long axis-views. The third and
gadolinium enhancement) expressed as percentage of the LV were segme
descending coronary artery territory affecting the anteroseptum (small
circumﬂex coronary artery territory, accompanied by microvascular obstr
on the T2 map (purple core, long black arrow). (C) Myocardial infarctionfrom 3 different study patients are shown in
Figure 2.
RIC reduced MI s i ze in STEMI pat ients .
Compared with the control patients, STEMI patients
who were administered RIC prior to PPCI had a
reduction in MI size (measured by CMR and ex-
pressed as a percent of the LV) of 27% (p ¼ 0.009)
(Figure 3A). Furthermore, we found that the RIC,
when compared with the control group, protocol
reduced absolute MI mass (p ¼ 0.029) (Table 3).
Finally, the RIC, when compared with the control
group, protocol also signiﬁcantly reduced plasma
levels of hsTnT at 24 h (p ¼ 0.037) (Figure 3B,
Table 3) and resulted in a nonsigniﬁcant reduction in
total 24-h AUC hsTnT (p ¼ 0.09) (Figure 3B, Table 3).
In a multivariable analysis adjusting for the effects
of baseline variables (age, sex, body mass index,
smoking, hypertension, dyslipidemia, diabetes,
family history of coronary artery disease, pre-infarct
angina, ischemia time, BARI score, APPROACH score)(orange-yellow area, short-axis view) and late gadolinium enhancement to assess myocardial
fourth images of row C illustrate how the areas of edema (increased T2 values) and infarct (late
nted in ImageJ. (A) Subendocardial myocardial infarction (with good salvage) in the left anterior
black arrowheads). (B) Transmural myocardial infarction (with minimal salvage) in a dominant
uction (dark hypointense core, long white arrows), and signiﬁcant intramyocardial hemorrhage
in the inferior wall of the right coronary artery territory. CMR ¼ cardiac magnetic resonance.
FIGURE 3 MI Size of RIC Versus Control Patients
(A) Patients randomized to remote ischemic conditioning (RIC), when compared to control patients, sustained a signiﬁcantly smaller myocardial infarct (MI) size (percent
of left ventricle, %LV), as measured by late gadolinium enhancement cardiac magnetic resonance: 18.0  10% (red) versus 24.5  12.0% (blue); p ¼ 0.009. Individual
values are plotted for all cardiac magnetic resonance subjects. Dashed line is the mean. (B) Patients randomized to RIC (dashed line), when compared to control patients
(solid line), sustained a smaller MI size (area-under-the-curve high-sensitivity [hs] troponin T) (p ¼ 0.09) and was signiﬁcantly smaller at 24 h. *p ¼ 0.037. The data was
skewed, and the bootstrap method used to calculate standard error of medians. Values are median  SEM.
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184the reduction in MI size remained statistically sig-
niﬁcant (p ¼ 0.025).
RIC reduced myocard ia l edema in STEMI
pat ients . With RIC, the extent of myocardial edema
delineated by T2-mapping CMR was reduced by 19%
compared with that of the control patients (p ¼ 0.003)
(Figure 4A, Table 3). As expected, within the AAR,
when compared to the remote myocardium, there
was a signiﬁcant increase in mean T2 values in both
RIC (p # 0.0001) (Figure 4B, Table 3) and control pa-
tients (p < 0.0001) (Figure 4B). However, the RIC,
when compared with the control, protocol also
resulted in a modest but signiﬁcant reduction in
mean T2 values within the AAR (p ¼ 0.001)
(Figure 4B). There was no reduction in mean T2 values
within the remote myocardium between the RIC and
control groups (p ¼ 0.633) (Figure 4B, Table 3). In a
multivariable analysis that adjusted for the effects of
baseline variables (age, sex, body mass index, smok-
ing, hypertension, dyslipidemia, diabetes, family
history of coronary artery disease, pre-infarct angina,
ischemia time, BARI score, APPROACH score), the
reduction in edema extent remained statistically
signiﬁcant (p ¼ 0.003).
RIC improved myocard ia l sa lvage in STEMI
pat ients . Because RIC was found to reduce the
extent of myocardial edema, this precluded its use asa measure of the AAR and its validity to calculate
MSI. However, using CMR-independent angiographic
jeopardy scores (BARI and APPROACH) to estimate
the AAR (Table 2), we found that the MSI was
increased by >50% with the RIC, when compared
with the control, protocol (p ¼ 0.03) (Table 3).
DISCUSSION
This study shows that RIC saves the myocardium
from infarction in STEMI patients treated by PPCI. It
reduced MI size by 27% (both absolute in terms of
grams of myocardial tissue and as a percent of the LV)
and increased the MSI by >50%. There was also a
signiﬁcant reduction (19%) in hsTnT levels at 24 h in
RIC-treated patients and a reduction in total 24-h
AUC hsTnT. Unexpectedly, when compared with the
control protocol, RIC reduced the extent of myocar-
dial edema, precluding the use of this CMR technique
to measure the AAR in the presence of RIC. The
intervention—4 arm cuff inﬂations and deﬂations of
a standard blood pressure cuff—is simple, low-cost,
and does not delay the onset of PPCI. The barriers
for the delivery of such a therapeutic intervention
across a healthcare system would be low.
The actual mechanism through which RIC protects
the myocardium from acute ischemia-reperfusion
TABLE 3 Study Outcomes
Control Group RIC Group
Difference
(95% CI) p Value
CMR ﬁndings 40 43
Infarct size, %LV 24.5  12 18.0  10 6.5 (1.7 to 11.3) 0.009
Absolute infarct mass, g 26.0  17 18.8  12 7.2 (0.7 to 13.7) 0.029
Indexed infarct mass, g/m2 12.9  8 9.4  6 3.5 (0.4 to 6.6) 0.026
T2 extent of edema, %LV 35.1  10 28.5  9 6.6 (2.4 to 10.9) 0.003
Mean T2 value, ms
Remote myocardium 50.1  2.0 49.9  2.5 0.2 (-0.8 to 1.2) 0.633
Infarct zone 73.1  6.1 68.7  5.8 4.32 (1.7–6.9) 0.001
Myocardial salvage index
Using CMR to estimate AAR 0.26 (0.15 to 0.42) 0.35 (0.16 to 0.57) -0.07 (-0.17 to 0.03) 0.171
Using BARI to estimate AAR 0.27  0.30 0.41  0.28 -0.14 (-0.27 to -0.02) 0.028
Using APPROACH to estimate AAR 0.28  0.29 0.42  0.29 -0.14 (-0.27 to -0.01) 0.031
MVO 22 (55) 20 (47) 0.440
Left ventricular volumes and mass
LVEDV, ml 152.2  31 154.9  31 -2.8 (-16.5 to 10.9) 0.687
LVESV, ml 65.7  27 65.3  24 0.4 (-10.8 to 11.5) 0.947
SV, ml 86.5  16 89.6  17 -3.2 (-10.3 to 3.9) 0.379
EF, % 57.9  10 59.0  10 -1.1 (-5.4 to 3.2) 0.603
Mass, g 165.0  36 163.0  37 2.0 (-13.9 to 17.8) 0.805
Indexed left ventricular volumes and mass
LVEDVI, ml/m2 76.1  13 77.2  13 -1.1 (-7.0 to 4.8) 0.712
LVESVI, ml/m2 32.8  12 32.5  12 0.2 (-5.0 to 5.5) 0.936
SVI, ml/m2 43.3  7 44.6  7 -1.3 (-4.4 to 1.8) 0.403
Mass-I, g/m2 82.1  13 80.8  13 1.3 (-4.4 to 7.0) 0.651
hs troponin T, ng/l 84 89
0 h 72 (26 to 206) 65 (23 to 115) -7 (-43 to 26) 0.128
6 h 3,632 (1,000 to 7,612) 2,937 (1,077 to 6,598) -695 (-2,154 to 758) 0.386
12 h 4,178 (1,867 to 6,598) 3,443 (1,475 to 5,950.5) -735 (-1,747 to 382) 0.288
24 h 2,736 (1,427 to 4,873) 2,296 (981 to 4,008) -440 (-1,201 to 396) 0.037
Total 24-h AUC 87,566 (34,992 to 133,640) 65,244 (26,841 to 111,600) -22,322 (-47,844 to 10,248) 0.088
Values are n, mean  SD, median (interquartile range), or n (%).
AUC ¼ area under the curve; EF ¼ ejection fraction; hs ¼ high sensitivity; LVEDV ¼ left ventricular end-diastolic volume; LVEDVI ¼ left ventricular end-diastolic volume index;
LVESV ¼ left ventricular end-systolic volume; LVESVI ¼ left ventricular end-systolic volume index; Mass-I ¼mass index; MVO ¼microvascular obstruction; SV ¼ stroke volume;
SVI ¼ stroke volume index; other abbreviations as in Tables 1 and 2.
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185currently remains unclear, although it has been sug-
gested that a neurohormonal pathway conveys the
cardioprotective signal from the remotely condi-
tioned arm to the heart (4). The current paradigm
suggests that an as yet unidentiﬁed humoral factor
produced in response to the remote conditioning
stimulus, which then conveys the protective signal to
the heart, where known cardioprotective pathways
are then activated (4). Interestingly, it appears that an
intact neural pathway to the limb is required for the
production of the humoral factor (31,32). Whatever
the putative mechanism, RIC has been previously
reported to protect the heart against acute ischemia-
reperfusion injury in a number of different clinical
settings including coronary artery bypass graft sur-
gery (6,7), and elective PCI (8,33). More recently, 2
pioneering clinical studies have investigated theeffect of RIC in STEMI patients treated by PPCI
(9,10,34). In a small trial of 33 STEMI patients per
group, Rentoukas et al. (9) failed to demonstrate any
beneﬁt with an abbreviated RIC protocol (three 4-min
cycles of upper arm cuff inﬂation/deﬂation) in terms
of ST-segment resolution and peak troponin I levels.
In a larger study comprising 142 STEMI patients,
Bøtker et al. (10) reported that RIC using the standard
protocol (four 5-min cycles of upper arm cuff inﬂa-
tion/deﬂation) delivered in the ambulance, while
transferring to the PPCI center, improved myocardial
salvage assessed by single-photon emission com-
puted tomography analysis 1 week post-PPCI. How-
ever, there was no reduction in absolute MI size seen
in that study (10). Furthermore, although follow-up of
this cohort seemed to suggest long-term beneﬁt, the
primary composite endpoint of major adverse cardiac
FIGURE 4 Reduction in Myocardial Edema and T2 Values in RIC Versus Control Patients
(A) In patients randomized to remote ischemic conditioning (RIC), the extent of myocardial edema delineated by quantitative T2-mapping cardiac magnetic resonance
(percent of the left ventricle, %LV) was signiﬁcantly reduced when compared with that of control patients: 28.5  9.0% (red) versus 35.1  10.0% (blue); p ¼ 0.003.
Individual values are plotted for all cardiac magnetic resonance subjects. Dashed line is themean. (B) Graph shows that in patients randomized to RIC, mean T2 values in the
area at risk assessed by quantitative T2-mapping cardiac magnetic resonance were signiﬁcantly reduced when compared with that of control patients (p¼0.001). However,
there was no signiﬁcant difference in mean T2 values in the remote, noninfarcted myocardium between RIC and control patients (p¼ 0.633). Values are mean SEM (error
bars) and median with IQR (box plot). The circle () represents 1 outlying patient.
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186and cerebrovascular event was driven by noncardiac
mortality (35).
The reason for the positive effect of RIC in our
study in terms of MI size reduction may relate to a
number of factors: 1) we delivered the standard RIC
protocol on arrival at the PPCI center; 2) we only
selected STEMI patients with complete occlusion in
the infarct-related artery (pre-PPCI TIMI ﬂow grade
0), as these patients were less likely to have sponta-
neously reperfused and therefore most likely to
beneﬁt from RIC; and 3) we used CMR to measure the
MI size reduction, which would be expected to be
more sensitive than either serum cardiac enzymes
and/or single-photon emission computed tomogra-
phy analysis (36).
The ability to assess the cardioprotective efﬁcacy
of a novel therapeutic intervention in STEMI patients
treated by PPCI, can be optimized by measuring MSI.
The MSI offers a more sensitive measure of car-
dioprotective efﬁcacy in cases where absolute MI sizereduction is not detectable between the therapeutic
intervention and control, because it “normalizes”
for the differences in the AAR that exist between
STEMI patients. T2-weighted CMR is a histologically
validated, noninvasive, imaging technique for retro-
spectively measuring the AAR (13–15), but it has
evoked controversy, and traditional sequences (e.g.,
black-blood STIR) are recognized to have limitations
(37,38). Newer sequences have improved on this
(39,40). We chose to use T2-mapping CMR in this
study for the following reasons: there is evidence to
support that it is more robust when compared with
traditional STIR imaging (21); it has recently been
histologically validated (41); and it provides a data
output map that is quantitative.
We found that RIC not only reduced the extent of
myocardial edema, but it also lowered T2 values
within the AAR. Similarly, Thuny et al. (18) found that
ischemic post-conditioning, another “mechanical”
therapeutic intervention for reducing myocardial
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187reperfusion injury in STEMI patients, also reduced
myocardial edema and the signal hyperintensity,
which was delineated by traditional STIR T2-weighted
CMR imaging. These ﬁndings suggest that for these
speciﬁc interventions, CMR edema imaging should
not be used to measure the AAR and calculate MSI,
and other measures of AAR should be considered
(e.g., single-photon emission computed tomography
or angiographic jeopardy scores (25–28)).
In contrast, other therapeutic interventions for
preventing acute ischemia-reperfusion injury in PPCI-
treated STEMI patients—exenatide (17); therapeutic
hypothermia (16); metoprolol (42)—have improved
myocardial salvage without affecting the extent of
myocardial edema delineated by T2-weighted CMR.
This suggests that whether the therapeutic interven-
tion affects myocardial edema may be speciﬁc to the
therapy under investigation. Further work is needed
to better understand the pathophysiology of myocar-
dial edema in the setting of a reperfused MI.
STUDY LIMITATIONS. A large number of patients
were randomized but were not included in the ﬁnal
CMR analysis (Figure 1). The main reasons for this
included: 1) patient randomization took place prior
to coronary angiography, before a deﬁnitive diag-
nosis of STEMI could be conﬁrmed; and 2) a pro-
portion of randomized patients had pre-PCI TIMI
ﬂow grade >0 and were thus excluded. Despite
achieving a signiﬁcant reduction in the primary
study endpoint, we found only a trend to reduction
in hsTnT. We believe that the study was underpow-
ered for this secondary endpoint and recruitmentwas designed to detect MI size by a more sensitive
method (CMR). This has also been seen in similar,
yet positive studies (10).
CONCLUSIONS
In this randomized study, we have demonstrated that
RIC delivered on arrival in-hospital can reduce MI
size assessed by CMR, in STEMI patients treated by
PPCI. Importantly, RIC was also found to reduce the
extent of myocardial edema, thereby precluding its
use to measure the AAR and calculate the MSI for
this therapeutic intervention. A large multicenter
randomized controlled clinical trial is now needed to
investigate whether the reduction in MI size we
observed will result in improved clinical outcomes in
STEMI patients treated by PPCI.
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